Updates from The Motley Fool

Latest updates on Illumina from Fool.com.

Stock Performance

ILMN vs. S&P 500 | 2 Year Performance
ILMN 1-Day Stock Chart
ILMN 5-Day Stock Chart
ILMN 1-Month Stock Chart
ILMN 3-Month Stock Chart
ILMN 6-Month Stock Chart
ILMN 1-Year Stock Chart
ILMN 2-Year Stock Chart
ILMN 5-Year Stock Chart
View Interactive ILMN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Illumina.
Current Price: $138.90
Prev Close: $134.97
Open: $134.59
Bid: $136.88
Ask: $139.00
Day's Range: $134.11 - $140.00
52wk Range: $127.10 - $242.37
Volume: 2,073,665
Avg Vol 1,775,787
Market Cap: $20.33B
P/E (ttm): 46.54
EPS (ttm): $3.10
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Illumina.
CAPS Rating 4 out of 5
1011 Outperform
60 Underperform
CAPS All Stars
240 Outperform
13 Underperform

How do you think Illumina will perform against the market?

You pick for Illumina is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jay Flatley, CEO

99% Approve

Based on 182 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Illumina.

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers